Method of preparing oligomeric compounds using modified coupling protocols
US-2015368288-A1 · Dec 24, 2015 · US
US12398170B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12398170-B2 |
| Application number | US-202017771089-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 28, 2020 |
| Priority date | Oct 28, 2019 |
| Publication date | Aug 26, 2025 |
| Grant date | Aug 26, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a nucleoside derivative represented by the following formula (1): or a salt thereof, wherein R 1 represents an alkoxy group, a hydrogen atom or a halogen atom; R 2 and R 4 , which may be the same as or different from each other, each represents a hydrogen atom, a protective group for a hydroxyl group, a phosphate group, a protected phosphate group, or —P(═O) n R 5 R 6 in which n represents 0 or 1, R 5 and R 6 , which may be the same as or different from each other, each represents a hydrogen atom, a hydroxyl group, a protected hydroxyl group, a mercapto group, a protected mercapto group, an alkoxy group, a cyanoalkoxy group, an amino group, or a substituted amino group, provided that when n is 1, both R 5 and R 6 cannot be the hydrogen atom at the same time; R 3 represents —(CH 2 ) m NHR 7 in which m represents an integer of 1 to 6, R 7 represents a hydrogen atom, an alkyl group, an alkenyl group or a protective group for an amino group; and B represents a purin-9-yl group, a 2-oxo-pyrimidin-1-yl group, a substituted purin-9-yl group, or a substituted 2-oxo-pyrimidin-1-yl group.
Opening claim text (preview).
The invention claimed is: 1. A nucleoside derivative represented by the following formula (1): or a salt thereof, wherein R 1 represents a methoxy group; R 2 and R 4 , which may be the same as or different from each other, each represents a hydrogen atom, a protective group for a hydroxyl group, a phosphate group, a protected phosphate group, or —P (=O) n R 5 R 6 in which n represents 0 or 1, R 5 and R 6 , which may be the same as or different from each other, each represents a hydrogen atom, a hydroxyl group, a protected hydroxyl group, a mercapto group, a protected mercapto group, an alkoxy group, a cyanoalkoxy group, an amino group, or a substituted amino group, provided that when n is 1, both R 5 and R 6 cannot be the hydrogen atom at the same time; R 3 represents —(CH 2 ) m NHR 7 in which m represents 2, R 7 represents a hydrogen atom, an alkyl group, an alkenyl group or a protective group for an amino group; and B represents a purin-9-yl group, a 2-oxo-pyrimidin-1-yl group, a substituted purin-9-yl group, or a substituted 2-oxo-pyrimidin-1-yl group. 2. The nucleoside derivative or the salt thereof according to claim 1 , wherein R 7 represents a hydrogen atom. 3. An oligonucleotide derivative comprising at least one partial structure represented by the following formula (2): or a salt thereof, wherein, R 1 represents a methoxy group; R 3 represents —(CH 2 ) m NHR 7 in which m represents 2, and R 7 represents a hydrogen atom, an alkyl group, an alkenyl group, or a protective group for an amino group; and B represents a purin-9-yl group, a 2-oxo-pyrimidin-1-yl group, a substituted purin-9-yl group, or a substituted 2-oxo-pyrimidin-1-yl group. 4. The oligonucleoside derivative or the salt thereof according to claim 3 , wherein R 7 represents a hydrogen atom. 5. An siRNA comprising the oligonucleotide derivative or the salt thereof according to claim 3 as an active ingredient.
interfering nucleic acids [NA] · CPC title
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title
with ribosyl as saccharide radical · CPC title
Other alkyl chain · CPC title
of the sugar · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.